Cargando…

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”

Allergen immunotherapy (AIT) is a guidelines-approved, disease-modifying treatment option for respiratory allergies, including allergic rhinitis (AR) induced by pollen. The various AIT regimens employed to date in pollen-induced AR can be classified as continuous (i.e. year-round) or discontinuous (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demoly, Pascal, Calderon, Moises A, Casale, Thomas B, Malling, Hans-Jørgen, Wahn, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418040/ https://www.ncbi.nlm.nih.gov/pubmed/25941566 http://dx.doi.org/10.1186/s13601-015-0061-z

Ejemplares similares

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
por: Didier, Alain, et al.
Publicado: (2012)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
por: Proctor, Thomas, et al.
Publicado: (2020)

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
por: Schäfer, Udo, et al.
Publicado: (2017)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
por: Worm, Margitta, et al.
Publicado: (2014)

Comparison of tear proteome in allergic rhinoconjunctivitis patients and controls with respect to pollen season
por: Tomazic, P. V., et al.
Publicado: (2018)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
por: Blin, Patrick, et al.
Publicado: (2018)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose
por: Demoly, Pascal, et al.
Publicado: (2015)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2021)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
por: Ueda, Shoko, et al.
Publicado: (2022)

Evaluation of the frequency and severity of seasonal allergic rhinoconjunctivitis caused by grass pollen in children with hazelnut sensitization
por: Cavkaytar, O, et al.
Publicado: (2013)

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
por: Rønborg, Steen M, et al.
Publicado: (2012)

Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
por: Poole, Chris D, et al.
Publicado: (2014)

Allergic rhinoconjunctivitis
por: Miraglia del Giudice, Michele, et al.
Publicado: (2020)

The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey
por: Calderon, Moises A., et al.
Publicado: (2015)

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
por: Nurmatov, Ulugbek, et al.
Publicado: (2017)

Sublingual immunotherapy with a carbamylated monomeric allergoidin cat-allergic patients suffering from rhinoconjunctivitis and/or allergic asthma. A multicenter, cross-sectional survey
por: Hauswald, Bettina
Publicado: (2015)

Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
por: Ellis, Anne K., et al.
Publicado: (2021)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
por: Horak, F, et al.
Publicado: (2009)

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis
por: Pfaar, O., et al.
Publicado: (2017)

Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
por: Tang, Rui, et al.
Publicado: (2022)

Induction of Eosinophilic Esophagitis by Sublingual Pollen Immunotherapy
por: Miehlke, Stephan, et al.
Publicado: (2013)

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
por: Verheggen, Bram G, et al.
Publicado: (2015)

Allergic Rhinoconjunctivitis: the Role of Histamine
por: Andersson, M., et al.
Publicado: (1994)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g89kt6baicrm5gqod44bagufn5